GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer

NCT07581405 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma
Gastric Cancer

Interventions

DRUG: Neoadjuvant chemotherapy
DRUG: Olanzapine

Sponsor

University of Illinois at Chicago